| Primary |
| Diabetes Mellitus |
36.3% |
| Type 2 Diabetes Mellitus |
16.9% |
| Hypertension |
13.6% |
| Drug Use For Unknown Indication |
7.4% |
| Diabetes Mellitus Non-insulin-dependent |
3.6% |
| Product Used For Unknown Indication |
2.1% |
| Atrial Fibrillation |
2.0% |
| Suicide Attempt |
2.0% |
| Gastritis |
1.9% |
| Constipation |
1.8% |
| Hyperlipidaemia |
1.8% |
| Angina Pectoris |
1.7% |
| Insomnia |
1.7% |
| Depression |
1.6% |
| Basedow's Disease |
1.3% |
| Bronchitis |
1.0% |
| Essential Hypertension |
0.9% |
| Pain |
0.9% |
| Cerebral Infarction |
0.8% |
| Gastric Ulcer |
0.7% |
|
| Hypoglycaemia |
20.1% |
| Hypoglycaemic Coma |
11.0% |
| Interstitial Lung Disease |
7.7% |
| Blood Creatine Phosphokinase Increased |
7.4% |
| Renal Failure Acute |
5.0% |
| Medication Error |
4.3% |
| Renal Impairment |
4.0% |
| Rhabdomyolysis |
4.0% |
| Weight Decreased |
4.0% |
| Renal Failure |
3.7% |
| Syncope |
3.7% |
| Hypoglycaemic Encephalopathy |
3.0% |
| Suicide Attempt |
3.0% |
| Vomiting |
3.0% |
| Weight Increased |
3.0% |
| Blood Potassium Increased |
2.7% |
| Cerebrovascular Accident |
2.7% |
| Malaise |
2.7% |
| Stevens-johnson Syndrome |
2.7% |
| Death |
2.3% |
|
| Secondary |
| Diabetes Mellitus |
29.6% |
| Type 2 Diabetes Mellitus |
20.5% |
| Hypertension |
12.7% |
| Drug Use For Unknown Indication |
9.5% |
| Product Used For Unknown Indication |
6.8% |
| Diabetes Mellitus Non-insulin-dependent |
3.2% |
| Constipation |
2.7% |
| Hyperlipidaemia |
1.7% |
| Chronic Myeloid Leukaemia |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Angina Pectoris |
1.4% |
| Irritability |
1.4% |
| Cerebral Infarction |
1.2% |
| Prophylaxis |
1.1% |
| Blood Glucose Abnormal |
1.1% |
| Asthma |
0.9% |
| Insomnia |
0.9% |
| Suicide Attempt |
0.8% |
| Atrial Fibrillation |
0.8% |
| Gastritis |
0.8% |
|
| Hypoglycaemia |
33.0% |
| Hypoglycaemic Coma |
7.2% |
| Weight Decreased |
6.2% |
| Weight Increased |
4.6% |
| Liver Disorder |
4.5% |
| Tremor |
4.5% |
| Loss Of Consciousness |
4.0% |
| Pyrexia |
4.0% |
| Vomiting |
3.6% |
| Blood Glucose Increased |
3.4% |
| Thrombocytopenia |
3.4% |
| Renal Failure Acute |
2.9% |
| Renal Impairment |
2.9% |
| Hyperglycaemia |
2.6% |
| Death |
2.4% |
| Syncope |
2.4% |
| Liver Function Test Abnormal |
2.2% |
| Altered State Of Consciousness |
2.1% |
| Drug Ineffective |
2.1% |
| Rash |
2.1% |
|
| Concomitant |
| Diabetes Mellitus |
22.5% |
| Type 2 Diabetes Mellitus |
13.8% |
| Hypertension |
13.6% |
| Product Used For Unknown Indication |
11.8% |
| Drug Use For Unknown Indication |
8.8% |
| Diabetes Mellitus Non-insulin-dependent |
6.9% |
| Prophylaxis |
3.4% |
| Rheumatoid Arthritis |
3.2% |
| Pain |
2.0% |
| Hyperlipidaemia |
1.6% |
| Depression |
1.5% |
| Insomnia |
1.4% |
| Atrial Fibrillation |
1.4% |
| Constipation |
1.3% |
| Hepatitis C |
1.3% |
| Chronic Hepatitis C |
1.1% |
| Blood Cholesterol Increased |
1.0% |
| Hypercholesterolaemia |
1.0% |
| Asthma |
1.0% |
| Cardiac Failure |
1.0% |
|
| Weight Decreased |
25.1% |
| Vomiting |
10.2% |
| Nausea |
8.3% |
| Blood Glucose Increased |
8.2% |
| Myocardial Infarction |
7.1% |
| Weight Increased |
6.4% |
| Tremor |
3.8% |
| Hypoglycaemia |
3.0% |
| Renal Impairment |
2.8% |
| Drug Ineffective |
2.5% |
| Renal Failure Acute |
2.5% |
| Pneumonia |
2.5% |
| Pancreatitis |
2.5% |
| Pyrexia |
2.3% |
| Type 2 Diabetes Mellitus |
2.3% |
| Urinary Tract Infection |
2.3% |
| Rash |
2.1% |
| Liver Disorder |
2.1% |
| Renal Failure |
2.1% |
| Interstitial Lung Disease |
2.0% |
|
| Interacting |
| Diabetes Mellitus |
23.7% |
| Hypertension |
19.2% |
| Constipation |
9.1% |
| Dyslipidaemia |
6.4% |
| Neuropathy Peripheral |
6.4% |
| Drug Use For Unknown Indication |
5.5% |
| Asthma |
3.7% |
| Type 2 Diabetes Mellitus |
3.7% |
| Helicobacter Infection |
2.7% |
| Parkinson's Disease |
2.3% |
| Angina Pectoris |
1.8% |
| Eosinopenia |
1.8% |
| Insomnia |
1.8% |
| Neutropenia |
1.8% |
| Oesophageal Candidiasis |
1.8% |
| Product Used For Unknown Indication |
1.8% |
| Reflux Oesophagitis |
1.8% |
| Urinary Tract Infection |
1.8% |
| Oral Candidiasis |
1.4% |
| Upper Respiratory Tract Inflammation |
1.4% |
|
| Drug Interaction |
23.8% |
| Drug Effect Delayed |
16.7% |
| Hypoglycaemia |
16.7% |
| Rectal Prolapse |
9.5% |
| Renal Impairment |
9.5% |
| Hemiparesis |
4.8% |
| Therapeutic Response Increased |
4.8% |
| Blood Glucose Decreased |
2.4% |
| Muscle Spasms |
2.4% |
| Neutropenic Infection |
2.4% |
| Pressure Of Speech |
2.4% |
| Subdural Haematoma |
2.4% |
| Type 2 Diabetes Mellitus |
2.4% |
|
